On-treatment viral factors affect subsequent hepatitis B surface antigen seroclearance in patients treated with nucleos(t)ide analogs for > 10 years. - Hosaka T; Hikita H; Tahata Y; Yamada R; Murai K; Miyazaki M; Ishida H; Hosui A; Sakamori R; Tatsumi N; Doi Y; Ohkawa K; et al. (Journal of gastroenterology, 2026)